These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 9415712

  • 1. Neuropeptide Y inhibits chromaffin cell nicotinic receptor-stimulated tyrosine hydroxylase activity through a receptor-linked G protein-mediated process.
    Zheng J, Zhang P, Hexum TD.
    Mol Pharmacol; 1997 Dec; 52(6):1027-33. PubMed ID: 9415712
    [Abstract] [Full Text] [Related]

  • 2. Neuropeptide Y inhibition of nicotinic receptor-mediated chromaffin cell secretion.
    Hexum TD, Zheng J, Zhu J.
    J Pharmacol Exp Ther; 1994 Oct; 271(1):61-6. PubMed ID: 7965758
    [Abstract] [Full Text] [Related]

  • 3. Neuropeptide Y (18-36) modulates chromaffin cell catecholamine secretion by blocking the nicotinic receptor ion channel.
    Zheng J, Morrisett RA, Zhu J, Hexum TD.
    J Pharmacol Exp Ther; 1995 Aug; 274(2):891-7. PubMed ID: 7543575
    [Abstract] [Full Text] [Related]

  • 4. Neuropeptide Y enhances ATP-induced formation of inositol phosphates in chromaffin cells.
    Zheng J, Zhang P, Toews M, Hexum TD.
    Biochem Biophys Res Commun; 1997 Oct 09; 239(1):287-90. PubMed ID: 9345312
    [Abstract] [Full Text] [Related]

  • 5. Neuropeptide Y inhibits forskolin-stimulated adenylate cyclase in bovine adrenal chromaffin cells via a pertussis toxin-sensitive process.
    Zhu J, Li W, Toews ML, Hexum TD.
    J Pharmacol Exp Ther; 1992 Dec 09; 263(3):1479-86. PubMed ID: 1335068
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of nicotinic responses of bovine adrenal chromaffin cells by the protein kinase C inhibitor, Ro 31-8220.
    Marley PD, Thomson KA.
    Br J Pharmacol; 1996 Sep 09; 119(2):416-22. PubMed ID: 8886429
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of nicotinic acetylcholine receptor channels in bovine adrenal chromaffin cells by Y3-type neuropeptide Y receptors via the adenylate cyclase/protein kinase A system.
    Nörenberg W, Bek M, Limberger N, Takeda K, Illes P.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Apr 09; 351(4):337-47. PubMed ID: 7543184
    [Abstract] [Full Text] [Related]

  • 8. Neuropeptide Y secretion from bovine chromaffin cells inhibits cyclic AMP accumulation.
    Zheng J, Zhou G, Hexum TD.
    Life Sci; 2000 Jun 30; 67(6):617-25. PubMed ID: 12659167
    [Abstract] [Full Text] [Related]

  • 9. Nicotinic stimulation of catecholamine synthesis and tyrosine hydroxylase phosphorylation in cervine adrenal medullary chromaffin cells.
    Knowles PJ, Douglas SA, Bunn SJ.
    J Neuroendocrinol; 2011 Mar 30; 23(3):224-31. PubMed ID: 21121973
    [Abstract] [Full Text] [Related]

  • 10. Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1beta: role of neuropeptide Y and nitric oxide.
    Rosmaninho-Salgado J, Araújo IM, Alvaro AR, Mendes AF, Ferreira L, Grouzmann E, Mota A, Duarte EP, Cavadas C.
    J Neurochem; 2009 May 30; 109(3):911-22. PubMed ID: 19309436
    [Abstract] [Full Text] [Related]

  • 11. BIBP 3226 inhibition of nicotinic receptor mediated chromaffin cell secretion.
    Zhang P, Zheng J, Hexum TD.
    Eur J Pharmacol; 1998 Dec 04; 362(2-3):121-5. PubMed ID: 9874161
    [Abstract] [Full Text] [Related]

  • 12. Neuropeptide Y receptor-mediated sensitization of ATP-stimulated inositol phosphate formation.
    Drakulich DA, Walls AM, Toews ML, Hexum TD.
    J Pharmacol Exp Ther; 2003 Nov 04; 307(2):559-65. PubMed ID: 12970392
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Neuropeptide Y inhibits the nicotine-mediated release of catecholamines from bovine adrenal chromaffin cells.
    Higuchi H, Costa E, Yang HY.
    J Pharmacol Exp Ther; 1988 Feb 04; 244(2):468-74. PubMed ID: 3346832
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.
    Mahapatra NR, Mahata M, Mahata SK, O'Connor DT.
    J Hypertens; 2006 May 04; 24(5):895-904. PubMed ID: 16612252
    [Abstract] [Full Text] [Related]

  • 17. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
    Palea S, Corsi M, Rimland JM, Trist DG.
    Br J Pharmacol; 1995 May 04; 115(1):3-10. PubMed ID: 7647980
    [Abstract] [Full Text] [Related]

  • 18. Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion.
    Cavadas C, Céfai D, Rosmaninho-Salgado J, Vieira-Coelho MA, Moura E, Busso N, Pedrazzini T, Grand D, Rotman S, Waeber B, Aubert JF, Grouzmann E.
    Proc Natl Acad Sci U S A; 2006 Jul 05; 103(27):10497-10502. PubMed ID: 16798884
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.